StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — Worldwide operational (constant-currency) growth YoY (%) (%)

Form 8-K EX-99.2 Segment Sales Schedule

QuarterlyAnnual
Latest, Q2 2023
13.9%
Period ended Jul 2, 2023
Change on a year earlier
+6.4 pts
7.5% in Q2 2022
History
23 quarters
Since Q4 2017
Sources
23
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOver-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — Worldwide operational (constant-currency) growth YoY (%) (%)Year on yearSource
Q2 2023Jul 2, 202313.9%+6.4 ptsForm 8-K (a2023q2exhibit991.htm, filed 2023-07-20) ↗
Q1 2023Apr 2, 202315.8%-1468.2 ptsForm 8-K (a2023q1exhibit991.htm, filed 2023-04-18) ↗
Q4 2022Jan 1, 202313.7%-2.1 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
Q3 2022Oct 2, 20227.2%-11.0 ptsForm 8-K (a2022q3exhibit991.htm, filed 2022-10-18) ↗
Q2 2022Jul 3, 20227.5%-1.4 ptsForm 8-K (a2022q2exhibit991.htm, filed 2022-07-19) ↗
Q1 2022Apr 3, 20221,484.0%+1498.8 ptsForm 8-K (a2022q1exhibit991.htm, filed 2022-04-19) ↗
Q4 2021Jan 2, 202215.8%+17.3 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
Q3 2021Oct 3, 202118.2%+14.2 ptsForm 8-K (a2021q3exhibit991.htm, filed 2021-10-19) ↗
Q2 2021Jul 4, 20218.9%-1.8 ptsForm 8-K (a2021q2exhibit991final.htm, filed 2021-07-21) ↗
Q1 2021Apr 4, 2021-14.8%-40.6 ptsForm 8-K (a2021q1exhibit991final.htm, filed 2021-04-20) ↗
Q4 2020Jan 3, 2021-1.5%-6.4 ptsForm 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
Q3 2020Sep 27, 20204.0%-2.5 ptsForm 8-K (a2020q3exhibit991.htm, filed 2020-10-13) ↗
Q2 2020Jun 28, 202010.7%+7.9 ptsForm 8-K (a2020q2exhibit991.htm, filed 2020-07-16) ↗
Q1 2020Mar 29, 202025.8%+20.3 ptsForm 8-K (a2020q1exhibit991.htm, filed 2020-04-14) ↗
Q4 2019Dec 29, 20194.9%-1.5 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
Q3 2019Sep 29, 20196.5%-0.3 ptsForm 8-K (a2019q3exhibit991.htm, filed 2019-10-15) ↗

Breakdown

What makes up over-the-counter (otc) medicines (tylenol, motrin, zyrtec) — worldwide operational (constant-currency) growth yoy (%)

Cite this data

StockData. (2026). Johnson & Johnson Over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — Worldwide operational (constant-currency) growth YoY (%) (%), quarterly Q4 2017–Q2 2023 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch_otc_ops_yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.